Biological markers of depression : state of the art : proceedings of the International Congress on Biological Markers of Depression--State of the Art, held in Liège, Belgium, on 13-15 June, 1990
Author(s)
Bibliographic Information
Biological markers of depression : state of the art : proceedings of the International Congress on Biological Markers of Depression--State of the Art, held in Liège, Belgium, on 13-15 June, 1990
(International congress series, no. 932)
Excerpta Medica, 1991
Available at 7 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and indexes
Description and Table of Contents
Description
Over the last decade a growing number of research groups have focussed their interest on potential neuroendocrine and neurophysiological markers of depression, with very successful results. The debate on the actual usefulness of these biological parameters in the everyday diagnosis and treatment of depressive patients continues however. The 100th anniversary of the Department of Psychiatry at the University of Liege presented a timely opportunity to critically review the extensive literature now available on biological markers of depression. The four most widely used biological tests of depression were individually reviewed in a specific symposium by renowned international experts: dexamethasone suppression test (DST), sleep EEG, clonidine test, and endogenous evoked potentials. The philosophy of each of those symposia was threefold: first to critically assess the actual usefulness of each of those types of parameters for diagnostic confirmation and treatment prediction in depressive disorders; second, to discuss the pathophysiological mechanisms responsible for such distsurbances; and third, to discuss new prospects in the field.
Finally, another symposium reviewed the most promising antidepressants currently under development. This book presents the findings of the symposium held in Liege, with a short summary of the contents as outlined hereunder.
Table of Contents
Biological markers of depression: state of the art (M. Ansseau). Session I: Session on the DST (4 papers). Session II: Session on the clonidine test (6 papers). Session III: Session on sleep EEG (3 papers). Session IV: Session on evoked potentials (5 papers). Session V: Session on new antidepressants (7 papers). Index of authors. Subject index.
by "Nielsen BookData"